Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Aluminium adjuvants, typically referred to as 'alum', are the most commonly used adjuvants in human and animal vaccines worldwide, yet the mechanism underlying the stimulation of the immune system by alum remains unknown. Toll-like receptors are critical in sensing infections and are therefore common targets of various adjuvants used in immunological studies. Although alum is known to induce the production of proinflammatory cytokines in vitro, it has been repeatedly demonstrated that alum does not require intact Toll-like receptor signalling to activate the immune system. Here we show that aluminium adjuvants activate an intracellular innate immune response system called the Nalp3 (also known as cryopyrin, CIAS1 or NLRP3) inflammasome. Production of the pro-inflammatory cytokines interleukin-1beta and interleukin-18 by macrophages in response to alum in vitro required intact inflammasome signalling. Furthermore, in vivo, mice deficient in Nalp3, ASC (apoptosis-associated speck-like protein containing a caspase recruitment domain) or caspase-1 failed to mount a significant antibody response to an antigen administered with aluminium adjuvants, whereas the response to complete Freund's adjuvant remained intact. We identify the Nalp3 inflammasome as a crucial element in the adjuvant effect of aluminium adjuvants; in addition, we show that the innate inflammasome pathway can direct a humoral adaptive immune response. This is likely to affect how we design effective, but safe, adjuvants in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Akira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
Cryopyrin activates the inflammasome in response to toxins and ATP
Mariathasan, S., Weiss, D. S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., Lee, W. P., Weinrauch, Y., Monack, D. M., & Dixit, V. M. (2006) · Nature · doi:10.1038/nature04515 · Cited by 3,080
Recognition of microorganisms and activation of the immune response
Medzhitov, R. (2007) · Nature · doi:10.1038/nature06246 · Cited by 2,862
Targeted Disruption of the MyD88 Gene Results in Loss of IL-1- and IL-18-Mediated Function
Adachi, O., Kawai, T., Takeda, K., Matsumoto, M., Tsutsui, H., Sakagami, M., Nakanishi, K., & Akira, S. (1998) · Immunity · doi:10.1016/s1074-7613(00)80596-8 · Cited by 2,041
Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf
Mariathasan, S., Newton, K., Monack, D. M., Vucic, D., French, D. M., Lee, W. P., Roose-Girma, M., Erickson, S., & Dixit, V. M. (2004) · Nature · doi:10.1038/nature02664 · Cited by 1,839
Agostini, L., Martinon, F., Burns, K., McDermott, M. F., Hawkins, P. N., & Tschopp, J. (2004) · Immunity · doi:10.1016/s1074-7613(04)00046-9 · Cited by 1,768
Molecular identification of a danger signal that alerts the immune system to dying cells
Shi, Y., Evans, J. E., & Rock, K. L. (2003) · Nature · doi:10.1038/nature01991 · Cited by 1,684
Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration
Pétrilli, V, Papin, S., Dostert, C., Mayor, A., Martinon, F., & Tschopp, J. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402195 · Cited by 1,445
Kool, M., Soullié, T., van Nimwegen, M., Willart, M. A. M., Muskens, F., Jung, S., Hoogsteden, H. C., Hammad, H., & Lambrecht, B. N. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071087 · Cited by 993
Cited by
Items 401–500 of 1,002
Innate Immune Recognition of Yersinia pseudotuberculosis Type III Secretion
Auerbuch, V., Golenbock, D. T., & Isberg, R. R. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000686 · Cited by 99
“We initially examined the production of the inflammatory cytokine TNF-a because it is produced downstream of several cytosolic innate immune sensors [28], but not following inflammasome activation [33,34].”
BackgroundNLRP3 regulates macrophage M2 polarization through up-regulation of IL-4 in asthma
Liu, Y., Gao, X., Miao, Y., Wang, Y., Wang, H., Cheng, Z., Wang, X., Jing, X., Jia, L., Dai, L., et al. (2018) · Biochemical Journal · doi:10.1042/bcj20180086 · Cited by 90
Noe, S. M., Green, M. A., HogenEsch, H., & Hem, S. L. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.02.085 · Cited by 89
Aluminum adjuvants elicit fibrin-dependent extracellular traps in vivo
Munks, M. W., McKee, A. S., MacLeod, M. K. L., Powell, R. L., Degen, J. L., Reisdorph, N. A., Kappler, J. W., & Marrack, P. (2010) · Blood · doi:10.1182/blood-2010-03-275529 · Cited by 93
Immunophysiology of experimental food allergy
Berin, M. C., & Mayer, L. (2008) · Mucosal Immunology · doi:10.1038/mi.2008.72 · Cited by 96
The spectrum of ASIA: ‘Autoimmune (Auto-inflammatory) Syndrome induced by Adjuvants’
Agmon‐Levin, N., Hughes, G., & Shoenfeld, Y. (2012) · Lupus · doi:10.1177/0961203311429316 · Cited by 90
Trichothecene Mycotoxins Activate Inflammatory Response in Human Macrophages
Kankkunen, P., Rintahaka, J., Aalto, A., Leino, M. S., Majuri, M., Alenius, H. T., Wolff, H. J., & Matikainen, S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803309 · Cited by 100
Calcium phosphate nanoparticles as a new generation vaccine adjuvant
Lin, Y., Wang, X., Huang, X., Zhang, J., Xia, N., & Zhao, Q. (2017) · Expert Review of Vaccines · doi:10.1080/14760584.2017.1355733 · Cited by 92
Adjuvant physiochemistry and advanced nanotechnology for vaccine development
Ren, H., Jia, W., Xie, Y., Yu, M., & Chen, Y. (2023) · Chemical Society Reviews · doi:10.1039/d2cs00848c · Cited by 98
The inflammasome: in memory of Dr. Jurg Tschopp
Dagenais, M., Skeldon, A. M., & Saleh, M. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.159 · Cited by 105
Uric Acid-Driven Th17 Differentiation Requires Inflammasome-Derived IL-1 and IL-18
Conforti‐Andreoni, C., Spreafico, R., Qian, H. L., Riteau, N., Ryffel, B., Ricciardi‐Castagnoli, P., & Mortellaro, A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101408 · Cited by 105
“There is also considerable disagreement about the requirement for the NLRP3 inflammasome in mediating the immunostimulatory properties of aluminum-containing adjuvants (alum), which typically induce Th2 responses (9, 14, 30, 52).”
BackgroundMold, M. J., Shardlow, E., & Exley, C. (2016) · Scientific Reports · doi:10.1038/srep31578 · Cited by 100
Clinically feasible approaches to potentiating cancer cell-based immunotherapies
Seledtsov, V. I., Гончаров, А. Г., & Seledtsova, G. V. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1009814 · Cited by 94
“Recent data demonstrated that alum targets NOD-like receptor protein 3 (NLRP3), which interacts with the caspase recruitment domain (CARD)-containing adaptor protein ASC and protease caspase 1 to form a protein complex called inflammasome.(52) Once activated, the inflammasome is involved in processing pro-inflammatory…”
BackgroundMolecular and cellular mechanisms of inflammation
Kuprash, D. V., & Nedospasov, S. A. (2016) · Biochemistry (Moscow) · doi:10.1134/s0006297916110018 · Cited by 99
“Inflammasomes as intracellular signaling platforms involved in reactions of innate immunity and inflamma tion are able to respond not only to pathogen derived components but also to various endogenous signals that may occur under sterile conditions [16, 17], to inorganic environmental components [18] or to vaccine adj…”
BackgroundYang, W., Li, Y., & Boraschi, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044065 · Cited by 103
Polymorphisms in Inflammasome' Genes and Susceptibility to HIV-1 Infection
Pontillo, A., Oshiro, T. M., Girardelli, M., Kamada, A. J., Crovella, S., & Duarte, A. J. S. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3182392ebe · Cited by 87
Yang, X., Yin, Y., & Wang, H. (2008) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2008.11.003 · Cited by 98
Vaine, C. A., Patel, M. K., Zhu, J., Lee, E. J., Finberg, R. W., Hayward, R. C., & Kurt‐Jones, E. A. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1200492 · Cited by 95
Witte, C. E., Archer, K. A., Rae, C. S., Sauer, J., Woodward, J. J., & Portnoy, D. A. (2012) · Advances in immunology · doi:10.1016/b978-0-12-394590-7.00002-6 · Cited by 98
Genipin inhibits NLRP3 and NLRC4 inflammasome activation via autophagy suppression
Yu, S.-X., Du, C., Chen, W., Lei, Q.-Q., Li, N., Qi, S., Zhang, X.-J., Hu, G., Deng, X., Han, W., et al. (2015) · Scientific Reports · doi:10.1038/srep17935 · Cited by 90
Selection of Adjuvants for Enhanced Vaccine Potency
Wang, W., & Singh, M. (2011) · World Journal of Vaccines · doi:10.4236/wjv.2011.12007 · Cited by 94
“Aluminum adjuvants activate an intracellular innate immune response system, called the NALP3 inflammasome (also known as cryopyrin, CIAS1 or NLRP3) [32] and via NALP3, induce secretion of mature IL-1β, IL-18, and IL-33 in human and mouse macrophages [33].”
BackgroundThe science of vaccine adjuvants: advances in TLR4 ligand adjuvants
Reed, S. G., Hsu, F., Carter, D., & Orr, M. T. (2016) · Current Opinion in Immunology · doi:10.1016/j.coi.2016.06.007 · Cited by 90
Inhibition of the Inflammasome Activity of NLRP3 Attenuates HDM-Induced Allergic Asthma
Ma, M., Li, G., Qi, M., Jiang, W., & Zhou, R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.718779 · Cited by 97
“In Nlrp3, Il-1b, Asc and Caspase1 mice, the inhaled OVA-induced inflammatory response is reduced, indicating that activation of the NLRP3 inflammasome promotes the development of allergic asthma (17, 18).”
BackgroundKaur, B. P., & Secord, E. A. (2019) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2019.06.011 · Cited by 120
Mohr, E., Cunningham, A. F., Toellner, K., Bobat, S., Coughlan, R. E., Bird, R. A., MacLennan, I. C. M., & Serre, K. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004879107 · Cited by 98
Autoimmune/autoinflammatory syndrome induced by adjuvants (ASIA syndrome) in commercial sheep
Luján, L., Pérez, M. M., Salazar, E., de Haro, N. Á., Gimeno, M., Pinczowski, P., Irusta, S., Santamaría, J., Insausti, N., Cortés, Y., et al. (2013) · Immunologic Research · doi:10.1007/s12026-013-8404-0 · Cited by 95
“One important fact is the influence of low temperatures on the clinical detection of the chronic phase of the ovine ASIA syndrome, something that could be explained by the immunostimulatory properties of alum that activates an intracellular innate immune response system called the Nalp3 inflammasome or cryopyrin [9].”
BackgroundInjection Route and TLR9 Agonist Addition Significantly Impact Heroin Vaccine Efficacy
Bremer, P. T., Schlosburg, J. E., Lively, J. M., & Janda, K. D. (2014) · Molecular Pharmaceutics · doi:10.1021/mp400631w · Cited by 85
“25 Although a Th2 response was observed for both ip and sc administration routes, titers were 6-fold higher for ip.”
Mukherjee, S. P., Kostarelos, K., & Fadeel, B. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700815 · Cited by 89
Ridi, R. E., & Tallima, H. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.11.039 · Cited by 84
Gao, P., He, F.-F., Tang, H. R., Lei, C., Chen, S., Meng, X., Su, H., & Zhang, C. (2015) · Journal of Diabetes Research · doi:10.1155/2015/504761 · Cited by 87
Douagi, I., Gujer, C., Sundling, C., Adams, W. C. T., Smed‐Sörensen, A., Seder, R. A., Hedestam, G. B. K., & Loré, K. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802257 · Cited by 84
Magalhaes, J. G., Rubino, S. J., Travassos, L. H., Le Bourhis, L., Duan, W., Sellge, G., Geddes, K., Reardon, C., Lechmann, M., Carneiro, L. A., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015063108 · Cited by 83
Negative regulation of NLRP3 inflammasome signaling
Chen, S., & Sun, B. (2013) · Protein & Cell · doi:10.1007/s13238-013-2128-8 · Cited by 83
Potential adjuvantic properties of innate immune stimuli
Warshakoon, H. J., Hood, J. D., Kimbrell, M. R., Malladi, S. S., Wu, W. Y., Shukla, N. M., Agnihotri, G., Sil, D., & David, S. A. (2009) · Human Vaccines · doi:10.4161/hv.5.6.8175 · Cited by 93
Modulation of Immune Responses by Particulate Materials
Lebre, F., Hearnden, C. H. A., & Lavelle, E. C. (2016) · Advanced Materials · doi:10.1002/adma.201505395 · Cited by 92
Rabolli, V., Lison, D., & Huaux, F. (2015) · Particle and Fibre Toxicology · doi:10.1186/s12989-016-0150-8 · Cited by 100
“However, the implication of ATP and P2X7R in potassium efflux in the context of inhaled particles remains controversial since silica-induced IL-1β release by macrophages was not reduced by apyrase nor deficiency in P2X7R in other studies [117, 119, 120].”
BackgroundTeunissen, M. B. M., Haniffa, M. A., & Collin, M. P. (2011) · Current topics in microbiology and immunology · doi:10.1007/82_2011_169 · Cited by 98
“Another explanation is that alum directly triggers the NLRP3 inflammasome, which leads to the production of the pro-inflammatory cytokines IL-1b, IL-18, and IL-33 (Eisenbarth et al. 2008; Hornung et al. 2008).”
BackgroundPyroptosis and respiratory diseases: A review of current knowledge
Sun, J., & Li, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.920464 · Cited by 84
“In animal models, NLRP3 inflammasome has also been confirmed to play a key role in allergic asthma (92, 97).”
BackgroundNanotheranostics to target antibiotic-resistant bacteria: Strategies and applications
Bhattacharjee, R., Negi, A., Bhattacharya, B., Dey, T., Mitra, P., Preetam, S., Kumar, L., Kar, S., Das, S. S., Iqbal, D., et al. (2023) · OpenNano · doi:10.1016/j.onano.2023.100138 · Cited by 93
Immunostimulatory activity of haptenated proteins
Palm, N. W., & Medzhitov, R. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809403105 · Cited by 90
Dai, X., Li, X., Zhu, S., Li, M., Zhao, Y. P., Talukder, M., Li, Y., & Li, J. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c06534 · Cited by 83
Programmed Cell Death in Asthma: Apoptosis, Autophagy, Pyroptosis, Ferroptosis, and Necroptosis
Liu, L., Zhou, L., Wang, L., Zheng, P., Zhang, F., Mao, Z., Zhang, H., & Liu, H. (2023) · Journal of Inflammation Research · doi:10.2147/jir.s417801 · Cited by 89
“Furthermore, NLRP3-/-, ASC-/-, and IL-1R-/- mice had more slight pathological changes in AHR, airway mucus secretion, and airway inflammation than WT mice.(153,154) Consistent findings were also found in the asthma murine models induced by HDM, Der f1, and TDI.”
BackgroundBeyond pattern recognition: NOD-like receptors in dendritic cells
Krishnaswamy, J. K., Chu, T., & Eisenbarth, S. C. (2013) · Trends in Immunology · doi:10.1016/j.it.2012.12.003 · Cited by 93
Self-citationPosttranslational Regulation of the NLR Family Pyrin Domain-Containing 3 Inflammasome
Shim, D.-W., & Lee, K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01054 · Cited by 85
“Among a number of inflammasomes, the NLR family pyrin domain (PYD)-containing 3 (NLRP3) inflammasome is the most well studied, because it responds to infectious pathogens, such as Sendai virus, adenovirus, influenza virus (3), Escherichia coli, Staphylococcus aureus (4), and host-derived damage-associated molecular pa…”
BackgroundThe adjuvant GLA-SE promotes human Tfh cell expansion and emergence of public TCRβ clonotypes
Hill, D. L., Pierson, W., Bolland, D. J., Mkindi, C., Carr, E. J., Wang, J., Houard, S., Wingett, S. W., Audran, R., Wallin, E. F., et al. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20190301 · Cited by 83
“, 2016), Alum does not act through TLRs but instead may act via the inflammasome (Eisenbarth et al., 2008).”
BackgroundAdjuvants for Leishmania vaccines: from models to clinical application
Raman, V. S., Duthie, M. S., Fox, C. B., Matlashewski, G., & Reed, S. G. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00144 · Cited by 89
“…pathways to induce type 2 inflammatory responses, characterized by the accumulation of eosinophils at the site of injection and the enhanced production of antigen-specific IgE and IgG1 (Li et al., 2007, 2008; Eisenbarth et al., 2008; Reed et al., 2009; Kuroda et al., 2011; Marichal et al., 2011).”
BackgroundThe NLRP 3 inflammasome: role in airway inflammation
Im, H., & Ammit, A. J. (2014) · Clinical & Experimental Allergy · doi:10.1111/cea.12206 · Cited by 79
IL-17 and neutrophils: unexpected players in the type 2 immune response
Allen, J. E., Sutherland, T. E., & Rückerl, D. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.03.001 · Cited by 81
“An ability of CLPs to activate the inflammasome might relate to earlier studies implicating low level triggering of the inflammasome with priming of the Th2 response [79].”
BackgroundStephen, J., Scales, H. E., Benson, R. A., Erben, D., Garside, P., & Brewer, J. M. (2017) · npj Vaccines · doi:10.1038/s41541-016-0001-5 · Cited by 81
Activating immunity: lessons from the TLRs and NLRs
Monie, T. P., Bryant, C. E., & Gay, N. J. (2009) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2009.06.011 · Cited by 84
U1-Small Nuclear Ribonucleoprotein Activates the NLRP3 Inflammasome in Human Monocytes
Shin, M. S., Kang, Y., Lee, N., Kim, S. H., Kang, K. S., Lazova, R. Z., & Kang, I. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103355 · Cited by 81
Optimization of current and future therapy for autoimmune diseases
Steinman, L., Merrill, J. T., McInnes, I. B., & Peakman, M. (2012) · Nature Medicine · doi:10.1038/nm.2625 · Cited by 84
NLRP3 inflammasome: Pathogenic role and potential therapeutic target for IgA nephropathy
Tsai, Y., Hua, K., Chen, A., Wei, C.-W., Chen, W., Wu, C.-Y., Chu, C., Yu, Y., Lo, C., & Ka, S. (2017) · Scientific Reports · doi:10.1038/srep41123 · Cited by 84
Graphene and the Immune System: A Romance of Many Dimensions
Mukherjee, S. P., Bottini, M., & Fadeel, B. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00673 · Cited by 83
“Recent studies showed that the aluminum adjuvant, alum triggered the release of IL-1β in macrophages and DCs in an NLRP3-dependent manner (97), and mice deficient in Nalp3 failed to mount a significant antibody response to an antigen administered with aluminum adjuvants (98).”
BackgroundShardlow, E., Mold, M. J., & Exley, C. (2018) · Allergy Asthma and Clinical Immunology · doi:10.1186/s13223-018-0305-2 · Cited by 89
Mice with diverse microbial exposure histories as a model for preclinical vaccine testing
Fiege, J. K., Block, K. E., Pierson, M. J., Nanda, H. A., Shepherd, F. K., Mickelson, C. K., Stolley, J. M., Matchett, W. E., Wijeyesinghe, S., Meyerholz, D. K., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.10.001 · Cited by 86
Genetic and Molecular Basis of Inflammasome-mediated Disease
Hoffman, H. M., & Brydges, S. D. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.135491 · Cited by 78
Nickel Induces Interleukin-1β Secretion via the NLRP3–ASC–Caspase-1 Pathway
Li, X., & Zhong, F. (2013) · Inflammation · doi:10.1007/s10753-013-9759-z · Cited by 88
Desbien, A. L., Reed, S. J., Bailor, H. R., Cauwelaert, N. D., Laurance, J. D., Orr, M. T., Fox, C. B., Carter, D., Reed, S. G., & Duthie, M. S. (2015) · European Journal of Immunology · doi:10.1002/eji.201444543 · Cited by 78
“Additionally we tested the activity of GLA-SE in mice deficient in the nod-like receptor (NLR) protein, NLRP3, a molecule linked to adjuvant mediated activation of the inflammasome [35].”
BackgroundMethodMaslanik, T., Tannura, K., Mahaffey, L., Loughridge, A. B., Benninson, L., Ursell, L., Greenwood, B. N., Knight, R., & Fleshner, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050636 · Cited by 77
Adjuvant-specific regulation of long-term antibody responses by ZBTB20
Wang, Y., & Bhattacharya, D. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20131821 · Cited by 83
“Alum initially acti vates macrophages and monocytic inflammatory DC precursors (Jordan et al., 2004; Eisenbarth et al., 2008; Franchi and Núñez, 2008; Kool et al., 2008a,b; Li et al., 2008; McKee et al., 2009).”
BackgroundInflammasomes and Their Activation
Khare, S., Luc, N., Dorfleutner, A., & Stehlik, C. (2010) · Critical Reviews™ in Immunology · doi:10.1615/critrevimmunol.v30.i5.50 · Cited by 77
Tan, H. Y., Yong, Y. K., Shankar, E. M., Paukovics, G., Ellegård, R., Larsson, M., Kamarulzaman, A., French, M. A., & Crowe, S. M. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502203 · Cited by 78
“Although inflammasome activation and pyroptosis contribute to pathogen clearance and induction of adaptive immune responses (60, 61), dysregulated NLRP3 inflammasome activity is regarded”
BackgroundImmunogenomics and systems biology of vaccines
Buonaguro, L., & Pulendran, B. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00971.x · Cited by 79
Inflammasome-Mediated Immunogenicity of Clinical and Experimental Vaccine Adjuvants
Reinke, S., Thakur, A., Gartlan, C., Bezbradica, J. S., & Milicic, A. (2020) · Vaccines · doi:10.3390/vaccines8030554 · Cited by 81
“Indeed, using an OVA immunisation model, Zanoni et al. demonstrated that oxPAPC potentiates adaptive immune responses in a caspase-11-dependent manner [52].”
BackgroundInfluentialCrompton, P. D., Mircetic, M., Weiss, G. E., Baughman, A., Huang, C., Topham, D. J., Treanor, J. J., Sanz, I., Lee, F. E.-H., Durbin, A. P., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803596 · Cited by 83
“Recently, alum has been shown to activate an intracellular innate immune response through the Nalp3 inflammasome and to direct Ab responses by mechanisms that, although incompletely understood, likely involve activation of Th2 cells (32).”
BackgroundBiopersistence and Brain Translocation of Aluminum Adjuvants of Vaccines
Gherardi, R. K., Eidi, H., Crépeaux, G., Authier, F., & Cadusseau, J. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00004 · Cited by 88
“Notably, the NLRP3 inflammasome was shown to be strongly activated by alum (25, 26), but this finally appeared unessential to the adjuvant effect (27, 28).”
BackgroundApproaches to enhancing immune responses stimulated by CpG oligodeoxynucleotides
Mutwiri, G., den Hurk, S. V. D. L., & Babiuk, L. A. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.12.004 · Cited by 76
Morris, G., Puri, B. K., & Frye, R. E. (2017) · Metabolic Brain Disease · doi:10.1007/s11011-017-0077-2 · Cited by 77
“aluminium hydroxide appears to induce dendritic cell and T-cell activation at least partly via NLRP3 activation (Kool et al. 2008a; Eisenbarth et al. 2008) although alternative routes such as”
BackgroundKono, H., Orlowski, G. M., Patel, Z., & Rock, K. L. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200136 · Cited by 75
“Macrophages that genetically lack NLRP3, apoptosis-associated speck-like protein containing a caspase-recruitment domain, or caspase-1 fail to produce any mature IL-1b in response to a number of sterile stimuli, including crystals of silica, urate, or other particles (14, 15).”
BackgroundChen, H., Lin, H. P., Xie, S., Huang, B., Qian, Y., Chen, K., Niu, Y., Shen, H., Cai, J., Li, P., et al. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.12.019 · Cited by 79
NLRP3 inflammasome and its role in autoimmune diseases: A promising therapeutic target
Ren, W., Sun, Y., Zhao, L., & Shi, X. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116679 · Cited by 88
Govindarajan, D., Meschino, S., Guan, L., Clements, D. E., ter Meulen, J. H., Casimiro, D. R., Coller, B.-A., & Bett, A. J. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.06.067 · Cited by 75
Pyroptosis in development, inflammation and disease
Pan, Y., Cai, W., Huang, J., Cheng, A., Wang, M., Yin, Z., & Jia, R. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.991044 · Cited by 79
The rhapsody of NLRPs: master players of inflammation … and a lot more
Zambetti, L. P., Laudisi, F., Licandro, G., Ricciardi‐Castagnoli, P., & Mortellaro, A. (2012) · Immunologic Research · doi:10.1007/s12026-012-8272-z · Cited by 83
“The adjuvant properties of aluminum hydroxide (alum) have similarly been shown to depend on activation of the NLRP3 inflammasome [30, 31].”
BackgroundControl of innate and adaptive immunity by the inflammasome
Çıracı, C., Janczy, J. R., Sutterwala, F. S., & Cassel, S. L. (2012) · Microbes and Infection · doi:10.1016/j.micinf.2012.07.007 · Cited by 85
Self-citationJacobson, L. S., Lima, H., Goldberg, M. F., Gocheva, V., Tsiperson, V., Sutterwala, F. S., Joyce, J. A., Gapp, B. V., Blomen, V. A., Chandran, K., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.400655 · Cited by 74
“Nlrp3 signaling pathways have been implicated in alum adjuvant activities (5, 6).”
BackgroundSelf-citationVaccari, M., Fourati, S., Gordon, S. N., Brown, D. R., Bissa, M., Schifanella, L., de Castro, I. S., Doster, M. N., Galli, V., Omsland, M., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0025-7 · Cited by 81
Onishi, M., Ozasa, K., Kobiyama, K., Ohata, K., Kitano, M., Taniguchi, K., Homma, T., Kobayashi, M., Sato, A., Katakai, Y., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402027 · Cited by 77
“Therefore, we examined the humoral responses in Asc mice and Caspase 1 mice, which are known to be deficient in inflammasome activation (32).”
BackgroundWilson, N. S., Duewell, P., Yang, B., Li, Y., Marsters, S. A., Koernig, S., Latz, E., Maraskovsky, E., Morelli, A. B., Schnurr, M. M., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302011 · Cited by 82
CARD8 p.C10X polymorphism is associated with inflammatory activity in early rheumatoid arthritis
Kastbom, A., Johansson, M., Verma, D., Söderkvist, P., & Rantapää‐Dahlqvist, S. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.106989 · Cited by 74
Affinity Maturation Is Impaired by Natural Killer Cell Suppression of Germinal Centers
Rydyznski, C. E., Cranert, S. A., Zhou, J. Q., Xu, H., Kleinstein, S. H., Singh, H., & Waggoner, S. N. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.08.075 · Cited by 73
“Nevertheless, alum stimulates inflammasome-dependent release of IL-1 and IL-18 (Eisenbarth et al., 2008; Pollock et al., 2003), where the latter is a known stim-ulus for NK cell activity.”
BackgroundOld Friends, immunoregulation, and stress resilience
Langgartner, D., Lowry, C. A., & Reber, S. O. (2018) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-018-2228-7 · Cited by 80
Wang, X., Sun, B., Liu, S., & Xia, T. (2016) · NanoImpact · doi:10.1016/j.impact.2016.08.002 · Cited by 74
Drug delivery carriers with therapeutic functions
Cai, S. S., Li, T., Akinade, T., Zhu, Y., & Leong, K. W. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113884 · Cited by 76
“Although alum-mediated induction of antigen-specific T cell responses hinges on DCs and is rested with MyD88 and uric acid, alum can still reinforce antigen-specific antibody responses of the animal model defi-cient in the TLR adaptors MyD88 and TRIF [84].”
BackgroundUpdate on Biology: Uric Acid and the Activation of Immune and Inflammatory Cells
Martinon, F. (2010) · Current Rheumatology Reports · doi:10.1007/s11926-010-0092-3 · Cited by 77
“Studies in mice have shown that the biological activity of uric acid crystals, including their proinflammatory activity, depends mainly on the activation of the NLRP3 inflammasome and the proteolytic maturation (activation) of IL-1β [12, 17 , 23].”
BackgroundInfluentialNew approaches to allergen immunotherapy
Gunawardana, N. C., & Durham, S. R. (2018) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2018.07.014 · Cited by 76
NLRP7: From inflammasome regulation to human disease
Carrière, J., Dorfleutner, A., & Stehlik, C. (2021) · Immunology · doi:10.1111/imm.13372 · Cited by 81
Heat shock proteins and immunity: Application of hyperthermia for immunomodulation
Torigoe, T., Tamura, Y., & Sato, N. (2009) · International Journal of Hyperthermia · doi:10.3109/02656730903315831 · Cited by 78
Induction of adaptive immunity by flagellin does not require robust activation of innate immunity
Sanders, C. J., Franchi, L., Yarovinsky, F., Uematsu, S., Akira, S., Núñez, G., & Gewirtz, A. T. (2009) · European Journal of Immunology · doi:10.1002/eji.200838804 · Cited by 72
“Intriguingly, recent reports indicate NLR-mediated IL-18 generation is central the mechanism by which aluminum-based adjuvants function [60,61].”
BackgroundMouse Models for Food Allergies: Where Do We Stand?
Schülke, S., & Albrecht, M. (2019) · Cells · doi:10.3390/cells8060546 · Cited by 87
“Alum and LPS both are classical immune activators: while Alum crystals activate the NLRP3 inflammasome [53], LPS is a ligand for “Toll”-like receptor 4 (TLR4), triggering APC activation via mitogen-activated protein kinase (MAPK)-and nuclear factor “kappa-light-enhancer” of activated B cells (NFκB)-signaling [54].”
BackgroundSchweneker, K., Gorka, O., Schweneker, M., Poeck, H., Tschopp, J., Peschel, C., Ruland, J., & Groß, O. (2013) · Immunobiology · doi:10.1016/j.imbio.2012.07.029 · Cited by 69
Pyroptosis: The missing puzzle among innate and adaptive immunity crosstalk
Hachim, M. Y., Khalil, B. A., Elemam, N. M., & Maghazachi, A. A. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mir0120-625r · Cited by 81
Insights Into Mucosal Innate Immune Responses in House Dust Mite-Mediated Allergic Asthma
Khweek, A. A., Kim, E., Joldrichsen, M. R., Amer, A. O., & Boyaka, P. N. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.534501 · Cited by 80
“In the ovalbumin model, absence of NLRP3 was associated with reduced allergic inflammation in the presence or absence of aluminum hydroxide (alum) adjuvant (119, 120).”
Hoffman, H. M., Scott, P., Mueller, J. L., Misaghi, A., Stevens, S. G., Yancopoulos, G. D., Murphy, A. J., Valenzuela, D. M., & Liu‐Bryan, R. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27456 · Cited by 74
Combination of adjuvants: the future of vaccine design
Mount, A. M., Koernig, S., Silva, A., Drane, D. P., Maraskovsky, E., & Morelli, A. B. (2013) · Expert Review of Vaccines · doi:10.1586/14760584.2013.811185 · Cited by 79
Macrophagic Myofaciitis a Vaccine (alum) Autoimmune-Related Disease
Israeli, E., Agmon‐Levin, N., Blank, M., & Shoenfeld, Y. (2010) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-010-8212-4 · Cited by 69
“vaccines [9]. Aluminum activates the intracellular innate immune system through the Nalp3 (also known as cryopyrin, CIAS1 or NLRP3) inflammasome and activation of dendritic cells (DCs) [ 10 ].”
BackgroundEmerging biomaterial-based strategies for personalized therapeutic in situ cancer vaccines
Viswanath, D. I., Liu, H., Huston, D. P., Chua, C. Y. X., & Grattoni, A. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121297 · Cited by 74
ALDOA maintains NLRP3 inflammasome activation by controlling AMPK activation
Bai, D., Du, J., Bu, X., Cao, W., Sun, T., Zhao, J., Zhao, Y., & Lu, N. (2021) · Autophagy · doi:10.1080/15548627.2021.1997051 · Cited by 75
“To further examine the function of LYG-202 on NLRP3 inflammasome activation in vivo, we employed alum-induced peritonitis, a mouse model of NLRP3-inflammasome-dependent inflammation [40].”
MethodDisparate adjuvant properties among three formulations of “alum”
Cain, D. W., Sanders, S. E., Cunningham, M. M., & Kelsoe, G. H. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.11.044 · Cited by 72
“Imject® alum, in contrast, is not licensed for human immunization, but is commonly used in animals as a comparator for new adjuvants [5-7], in tests of immunogenicity [8-10], and in mechanistic investigations of adjuvanticity [11-14].”
Background
Metadata
- Authors
- Eisenbarth, S. C., Colegio, O. R., O’Connor, W., Sutterwala, F. S., & Flavell, R. A.
- Affiliations
- Yale University (US)
- University of Iowa (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Flavell, Richard A.
- Venue
- Nature
- Published
- 2008-05-21
- Volume
- 453
- Issue
- 7198
- Pages
- 1122-1126
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4804622
- OpenAlex
- W1979991507
- Cited by
- 1,542
- References
- 45
- Citations by year
- 2026: 34 · 2025: 43 · 2024: 54 · 2023: 56 · 2022: 52 · 2021: 81 · 2020: 62 · 2019: 53 · 2018: 74 · 2017: 81 · 2016: 91 · 2015: 85 · 2014: 91 · 2013: 125 · 2012: 132
- FWCI
- 57.93
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- Bill and Melinda Gates Foundation
- National Institutes of Health
- National Heart, Lung, and Blood Institute (T32HL007974)
- National Institute of Allergy and Infectious Diseases (K08AI065517)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (T32AR007016)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- NLRP3 inflammasome, aluminum hydroxide adjuvant, vaccine adjuvants, innate immunity, macrophages, IL-1β, IL-18, caspase-1, ASC, humoral antibody response, adaptive immune response, Toll-like receptors, complete Freund's adjuvant
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Adjuvants, Immunologic, Alum Compounds, Animals, Antibodies, Carrier Proteins, Cytoskeletal Proteins, Enzyme Activation, T-Lymphocytes, Helper-Inducer, Immunity, Innate, Inflammation, Macrophages, Mice, Inbred C57BL, Potassium, Cell Death, Caspase 1, Interleukin-18, Apoptosis Regulatory Proteins, Mice, CARD Signaling Adaptor Proteins, Interleukin-1beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.